AAA February 2016 – Page 13

Mersana inks partnership with Takeda

US-based pharmaceutical company Mersana Therapeutics has signed a strategic partnership agreement with its Japan-based peer Takeda Pharmaceutical that is potentially worth more than $800m. Mersana will secure an upfront payment of $40m and another $20m once an investigational new drug application has been granted for the company’s lead drug candidate, XMT-1522, in the US. Takeda… Continue reading Mersana inks partnership with Takeda

Weekly corporate venturing deal net: 1-5 February 2016

US-based cybersecurity startup Lexumo completed a $4.9m seed round on Tuesday funded by research and development company Draper Laboratory, Accomplice and .406 Ventures. The capital will be used to build Lexumo’s ales and marketing teams, and develop and commercialise its platform, which continuously searches and indexes software to identify security vulnerabilities. Venture capital firm Arch… Continue reading Weekly corporate venturing deal net: 1-5 February 2016